Evidence map›Paper›PMID 41657117›Full record

Trial reportDiabetes, obesity & metabolism2026

Effects of coaching with data management system intervention or usual care on glycemic control in patients with type 2 diabetes: A multicentre, randomised controlled trial.

Marlo Verket, Larissa F Buitkamp, Niveditha Daneeza Dinesh Kanna, Andreas Thomas, Ralf Denger, Friedrich Petry, Oliver Schubert-Olesen, Wolfgang Stütz, Jörg Simon, Monika Pihusch and 12 more

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Marlo VerketDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0002-3361-3722
Larissa F BuitkampDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.
Niveditha Daneeza Dinesh KannaDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.
Andreas ThomasScientific Consulting, Pirna, Germany.ORCID https://orcid.org/0000-0002-6549-2793
Ralf DengerGemeinschaftspraxis Dr. med. Ralf Denger und Dr. med. Thomas Pfitzner, Friedrichsthal, Germany.
Friedrich PetryInternistische Gemeinschaftspraxis, Wetzlar, Germany.
Oliver Schubert-OlesenDiabeteszentrum Hamburg City, Hamburg, Germany.
Wolfgang StützMVZ hausärztliche Medizin und Diabetologie, Bretten, Germany.
Jörg SimonMVZ im Altstadt-Carree Fulda GmbH, Fulda, Germany.
Monika PihuschMVZ Praxis Pihusch Rosenheim, Rosenheim, Germany.
Iris DötschDiabetologische Schwerpunktpraxis am Kurfürstendamm, Berlin, Germany.
Gabriela KrobDiabeteszentrum Murnau, Murnau am Staffelsee, Germany.
Dietrich TewsMVZ Diabeteszentrum Dr. Tews GmbH, Geinhausen, Germany.
David StolzDiabetes Freiburg, Freiburg, Germany.
Dominik BergisDiabetes Clinic, Bad Mergentheim, Germany.ORCID https://orcid.org/0000-0002-4030-5744
Thorsten LenthePraxis Lenthe & Rietz, Leipzig, Germany.
Frank Schmidt-MergenthalerGemeinschaftspraxis Renningen, Renningen, Germany.
Elke DahlmannPraxis Dr. Dahlmann, Prüm, Germany.
Kathrin BoehmAssociation of Diabetes Advice and Training Professions in Germany e.V, Berlin, Germany.
Malte JacobsenDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0003-0780-0003
Dirk Müller-WielandDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0002-8807-6442
Julia BrandtsDepartment of Internal Medicine I, RWTH University Hospital Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0002-1141-1126

Funding

EvivaMed Germany GmbH
6 · The paper itself

Abstract

aimsIntegrating a diabetes management system (DMS) and personal coaching in patient care may reduce the burden of type 2 diabetes (T2DM) on patients and help address the multifaceted challenges associated with diabetes management. This study aims to assess the impact of the DMS with online coaching in patients with T2DM on changes in HbA1c levels, quality of life, and usability over 26 weeks. MATERIALS AND

methodsIn a multicentre, randomised, controlled trial, adults with T2DM were randomised 1:1 to either 52 weeks of DMS with remote coaching or to usual care by their diabetologist. The DMS enabled a digital diary of blood pressure, blood glucose, and other health parameters, while coaching sessions included structured assessments of individual patient needs. The primary endpoint was changes in the HbA1c level from baseline to 26 weeks. Secondary endpoints included health-related quality of life (SF-12), diabetes-related problems (PAID), and DMS usability (System Usability Scale) at 26-week follow-up.

resultsOne hundred and fourteen participants (49 females, 58 ± 11 years old [mean ± standard deviation], HbA1c: 8.3% ± 0.7%, body mass index [BMI]: 35.3 ± 7.9 kg/m

conclusionsDMS with coaching improved glycaemic control compared to usual care in patients with T2DM at 26-week follow-up.

Indexed as

Diabetes Mellitus, Type 2Glycemic ControlMentoringAgedBlood GlucoseFemaleGlycated HemoglobinHumansMaleMiddle AgedQuality of LifeTreatment OutcomeBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanclinical trialeffectivenessperceptionstype 2 diabetes

Identifiers

PMID41657117
PMCPMC12992191

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.